Product Information
LAMIVUDINE 10 MG/ML ORAL SOLN is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2176 per ML under NDC 57237027424. Its NADAC has been published 202 times since Aug 9, 2017.
FDA first approved this application on Nov 21, 2016. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/mL
Manufacturer
Rising Pharma Holdings Inc.NDC
57237027424
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA077695FDA Approved
11/21/2016
TE Code
AA
On Market Since
11/21/2016
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 10 MG/ML ORAL SOLN has been published 202 times since Aug 9, 2017, and over the history we have for it it has declined 33.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2176 per ML |
|---|---|
| All-time high | $0.3251 (Mar 14, 2018) |
| All-time low | $0.2174 (Nov 20, 2024) |
| 52-week high | $0.2653 |
| 52-week low | $0.2176 |
| Median price | $0.2624 |
| Average price | $0.2659 |
| Largest weekly change | -14.7% (Nov 20, 2024) |
| Weeks tracked | 202 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMIVUDINE 10 MG/ML ORAL SOLN?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 10 MG/ML ORAL SOLN, manufactured by Rising Pharma Holdings Inc., is $0.2176 per ML (NDC 57237027424), effective Aug 19, 2026.
How has the price of LAMIVUDINE 10 MG/ML ORAL SOLN changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 10 MG/ML ORAL SOLN has declined 33.1%. It has been tracked across 202 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 10 MG/ML ORAL SOLN?
Since Aug 9, 2017, the NADAC for LAMIVUDINE 10 MG/ML ORAL SOLN has ranged from a low of $0.2174 (Nov 20, 2024) to a high of $0.3251 (Mar 14, 2018), with a median of $0.2624 per ML.
Are there cheaper alternatives to LAMIVUDINE 10 MG/ML ORAL SOLN?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LAMIVUDINE 10 MG/ML ORAL SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures LAMIVUDINE 10 MG/ML ORAL SOLN?
LAMIVUDINE 10 MG/ML ORAL SOLN (NDC 57237027424) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.